Patents

US 9695119 B2: Methionine analogs and methods of using same

Granted
2017-07-04
Filed
2016-02-26 application 15054761
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.

Source: PVGPATDIS, file of 2026-04-10 (ipg170704.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Bioxiness Pharmaceuticals, Inc. 2 patentsUS company or organizationHercules, CABIOXINESS PHARMACEUTICALS, INC. Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Mansour BassiriNovato, CA3PVGPATDIS, file of 2026-04-10
Afsaneh RAHIMI-LARIJANINovato, CA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07CAcyclic or carbocyclic compoundsC07C323/60PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.